UNCY Shareholder Alert: Unicycive Therapeutics, Inc. Securities Class Action Lawsuit - Investors With Losses May Contact SueWallSt
A securities class action alleges Unicycive Therapeutics leaned on a contract manufacturer already cited by the FDA for cGMP deficiencies, without verifying the vendor's compliance status, before the same deficiencies triggered a second Complete Response Letter and a 39.1% single-day...